Biohaven Pharmaceutical biohavenpharma.com


Public list: Pharma Startups (6570) Neuroscience Startups (947)

Biohaven Pharmaceutical (NYSE: BHVN) is a clinical-stage biopharmaceutical company with a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company's product candidates are small molecules based on two distinct mechanistic platforms - calcitonin gene-related peptide, or CGRP, receptor antagonists and glutamate modulators - which have the potential to significantly alter existing treatment approaches across a diverse set of neurological indi...Show all

Biohaven Pharmaceutical (NYSE: BHVN) is a clinical-stage biopharmaceutical company with a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company's product candidates are small molecules based...Show all

Company (IPO / Went public)

Phone: 203-404-0410

Fax:

234 Church Street
Suite 304
New Haven, 06510
Connecticut, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Biohaven Pharmaceutical $80M May 4, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Biohaven Pharmaceutical Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 12 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Prodrugs riluzole and their method of use Feb 26, 2016 May 05, 2020 Patent
Prodrugs of riluzole and their method of use Aug 04, 2017 Feb 18, 2020 Patent
Riluzole prodrugs and their use Feb 26, 2016 Nov 26, 2019 Patent
Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosis Jun 24, 2013 Jul 23, 2019 Patent
Prodrugs of riluzole and their method of use Mar 15, 2013 Aug 08, 2017 Patent
See all 16 patents